RNA Analysis Transcriptomics Market: By Type, By Technology, By Application, and Region Forecast 2019-2030           

RNA Analysis Transcriptomics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Consumables, Instruments, Software, Services), By Technology (Microarrays, qPCR, Sequencing Technology), By Application (Drug Discovery, Diagnostics and Disease Profiling, Others), and Region Forecast 2019-2030           

RNA Analysis Transcriptomics Market size was valued at US$ 8,648.3 Million in 2023 and is poised to grow at a significant CAGR of 16.9% from 2024-2030. Transcriptomics is the study of the RNA transcripts set produced by the organisms genome. Transcriptome analysis allows researchers to learn about the sequence and function of DNA. The increased demand for specific genes, quantification of multiplexed RNA, various assay technologies, increased need for genetic testing and personalized medicine and rise in genetic variation and genetic mutation incidences drive the market demand.

The Consumables segment is anticipated to grow at a significant CAGR over the forecast years owing to expanding pharmaceutical R&D activity, as well as increased government financing for life sciences research. For example, in March 2022, the Government of Canada allocated $13.8 million in government funding to deploy genomics through ten downstream processing R&D initiatives. The growing emphasis on biomarker development and toxicogenomic, as well as the growing interest in outsourcing services, are likely to provide substantial potential possibilities for companies in the global RNA analysis/transcriptomics market.

RNA Analysis Transcriptomics market Key Developments

In June 2022, Fluent BioSciences a private funded biotechnology company launched the PIPseqTM technology for single-cell RNA analysis in laboratories. In February 2022, QIAGEN leading global provider of Sample partnered with Singular Genomics Systems Inc. to get their QIAseq kits validated.

Rna Analysis Transcriptomics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16.9%

Largest Market

North American

Fastest Growing Market

Asia-Pacific

RNA Analysis Transcriptomics Market Dynamics

The growth of the global transcriptomics market is majorly driven by a surge in demand for personalized medicine. Personalized medicine has entered mainstream clinical practice and transformed how many diseases are detected, categorized, and treated. It has become a fundamental focus of study in the healthcare business. These developments are notably visible in cancer.

The number of personalized medications, therapies, and diagnostic items has grown since 2006, according to the Personalized Medicine Coalition report (2017), and this trend is projected to continue in the future years. Moreover, market players focus on launching new products, acquisition, and collaboration. For instance, In 2020, Agilent Technologies leading life science company, launched its Sure Select XT HS2 RNA Reagent Kit.

Rna Analysis Transcriptomics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

16.9%

Type

  • Consumables
  • Instruments
  • Software
  • Services

Technology

  • Microarrays
  • qPCR
  • Sequencing Technology

Application

  • Drug Discovery
  • Diagnostics and Disease Profiling
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The rna analysis transcriptomics market report provides granular level information about the market size, regional market share and forecast from 2024-2030
  • The report covers in-detail insights about the competitors overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startups details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The global rna analysis transcriptomics market size was valued at US$ 8,648.3 million in 2023 and is expected to grow at a CAGR of 16.9% from 2024 to 2030.

The key players of rna analysis transcriptomics market are Agilent Technologies Inc., Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, Qiagen, Inc., Thermofisher Scientific .

North America is the fastest-growing region for rna analysis transcriptomics market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global RNA Analysis/ Transcriptomics Market Introduction
2.1. Global RNA Analysis/ Transcriptomics Market – Taxonomy
2.2. Global RNA Analysis/ Transcriptomics Market –Definitions
2.2.1. By Type
2.2.2. By Technology
2.2.3. By Application
2.2.4. By Region
3. Global RNA Analysis/ Transcriptomics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global RNA Analysis/ Transcriptomics Market Dynamic Factors - Impact Analysis
3.6. Global RNA Analysis/ Transcriptomics Market – Competition Landscape
4. Global RNA Analysis/ Transcriptomics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global RNA Analysis/ Transcriptomics Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Consumables
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Services
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global RNA Analysis/ Transcriptomics Market Forecast, By Technology, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Microarrays
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. qPCR
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Sequencing Technology
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global RNA Analysis/ Transcriptomics Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Drug Discovery
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostics and Disease Profiling
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global RNA Analysis/ Transcriptomics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Region, 2022-2028
8.6.1. North America RNA Analysis/ Transcriptomics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.7. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.7.1. Consumables
8.7.2. Instruments
8.7.3. Software
8.7.4. Services
8.8. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.8.1. Microarrays
8.8.2. qPCR
8.8.3. Sequencing Technology
8.9. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.9.1. Drug Discovery
8.9.2. Diagnostics and Disease Profiling
8.9.3. Others
8.10. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.10.1. USA
8.10.2. Canada
8.11. North America RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028
8.12. North America RNA Analysis/ Transcriptomics Market Dynamics – Trends
9. Europe RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Consumables
9.1.2. Instruments
9.1.3. Software
9.1.4. Services
9.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Microarrays
9.2.2. qPCR
9.2.3. Sequencing Technology
9.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Drug Discovery
9.3.2. Diagnostics and Disease Profiling
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. Germany
9.4.2. UK
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Rest of Europe
9.5. Europe RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028
9.6. Europe RNA Analysis/ Transcriptomics Market Dynamics – Trends
10. Asia-Pacific RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables
10.1.2. Instruments
10.1.3. Software
10.1.4. Services
10.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Microarrays
10.2.2. qPCR
10.2.3. Sequencing Technology
10.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Drug Discovery
10.3.2. Diagnostics and Disease Profiling
10.3.3. Others
10.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. ASEAN
10.4.5. Australia & New Zealand
10.4.6. Rest of Asia-Pacific
10.5. Asia-Pacific RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028
10.6. Asia-Pacific RNA Analysis/ Transcriptomics Market Dynamics – Trends
11. Latin America RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables
11.1.2. Instruments
11.1.3. Software
11.1.4. Services
11.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Microarrays
11.2.2. qPCR
11.2.3. Sequencing Technology
11.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Drug Discovery
11.3.2. Diagnostics and Disease Profiling
11.3.3. Others
11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
11.5. Latin America RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028
11.6. Latin America RNA Analysis/ Transcriptomics Market Dynamics – Trends
12. Middle East and Africa RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables
12.1.2. Instruments
12.1.3. Software
12.1.4. Services
12.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Microarrays
12.2.2. qPCR
12.2.3. Sequencing Technology
12.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Drug Discovery
12.3.2. Diagnostics and Disease Profiling
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Gulf Cooperation Council (GCC) Countries
12.4.2. Israel
12.4.3. South Africa
12.4.4. Rest of MEA
12.5. MEA RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028
12.6. MEA RNA Analysis/ Transcriptomics Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, By Technology & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Agilent Technologies Inc.
13.2.2. Bio-Rad Laboratories
13.2.3. F-Hoffmann La-Roche
13.2.4. Fluidigm Corporation
13.2.5. General Electric Company
13.2.6. Illuminia Inc.
13.2.7. Merck & Co. Inc
13.2.8. Promega Corporation
13.2.9. Qiagen, Inc.
13.2.10. Thermofisher Scientific .
14. Research Methodology
15. Key Assumptions and Acronyms

Key Market Players

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories
  • F-Hoffmann La-Roche
  • Fluidigm Corporation
  • General Electric Company
  • Illuminia Inc.
  • Merck & Co. Inc
  • Promega Corporation
  • Qiagen, Inc.
  • Thermofisher Scientific .

Related Industry Reports